Heidelberg Pharma signs option agreement with the Max Delbruck Center for BCMA antibodies Sep. 20, 2016
National Cancer Center of Japan and Ono sign comprehensive research collaboration agreement Sep. 16, 2016
Phase I data for CAR-modified T-cell immunotherapy in patients with non-Hodgkin's lymphoma Sep. 15, 2016
RSS